0000000000159066

AUTHOR

Pavone Macaluso M

showing 12 related works from this author

Water Chlorination and other environmental factors in bladder cancer. Result of a multicentre study.

2005

researchProduct

Ruolo della terapia di mantenimento e fattori di rischio ambientale nel carcinoma vescicale superficiale. Pazienti sottoposti a chemioterapia endoves…

2005

researchProduct

Environmental factors in superficial bladder cancer. Preliminary report of a prospective study

2004

researchProduct

Chemioterapia domiciliare nel carcinoma prostatico ormonorefrattario (HRPC). Studio di fase II del gruppo studio tumori urologici (GSTU).

2005

researchProduct

Sindromi prostatitiche croniche (SPC), Chronic Pelvic Pain Syndrome e cistite interstiziale. Semplice analogia o unità patogenetica? Risultati di uno…

2005

researchProduct

RISULTATI DI UNO STUDIO RANDOMIZZATO SULLA TOSSICITÀ E SUL RUOLO DEL MANTENIMENTO NELLA CHEMIOPROFILASSI ENDOVESCICALE PRECOCE DOPO TUR DI CARCINOMA …

2005

researchProduct

PROSTATA (PROSTATITI, IPERTROFIA PROSTATICA, CANCRO DELLA PROSTATA)

2008

PROSTATITI IPERTROFIA PROSTATICA CANCRO DELLA PROSTATASettore MED/24 - Urologia
researchProduct

Survival risk factors in T1G3 non-muscle-invasive (NMI) bladder cancer consevatively treated. Long term results.

2008

Introduction: The most relevant risk factor in T1G3 NMI transitional cell carcinoma of the bladder (TCCB) is the presence of Tis. The long term results of conservative management still are a matter of controversy. The role of BCG in preventing progression and death in this category of NMI TCCB is not definitely proved. The published experiences of conservative treatment of high risk TCCB often include unselected patients, small numbers and short follow-up. Immediate radical cystectomy is advocated by many urologists. Objectives: The aim of the study is to identify the survival risk factors in 236 selected patients conservatively treated. Methods: Between January 1976 and December 2005, 236 …

bladder cancer T1G3 conservative treatmentSettore MED/24 - Urologia
researchProduct

low dose oral chemotherapy for hormone refractory prostate carcnoma.Estramustine phosphate versus estramustine phosphate and etoposide. A randomised …

2006

researchProduct

Fattori di rischio ambientali nella storia naturale del carcinoma vescicale superficiale.

2004

researchProduct

Il carcinoma prostatico in Calabria e Sicilia.

2004

researchProduct

Chemioterapia adiuvante e fattori di rischio ambientale nel carcinoma vescicale superficiale a medio rischio di recidiva. Uno studio prospettico rand…

2004

researchProduct